Immune Efficacy of the EV71 Vaccine in Fujian Province, China: A Real-World Analysis of HFMD

Author:

Li Junrong1,Xie Fangqin1,Lin Guangcan1,Zhang Dongjuan1

Affiliation:

1. Fujian Provincial Center for Disease Control and Prevention, Fuzhou 350012, China

Abstract

EV71 vaccine immunization mainly protects the human population against severe and fatal HFMD and has a positive effect on reducing the overall incidence rates of HFMD and of hospitalized cases. In the analysis of data collected over 4 years, we compared HFMD’s incidence rate, severity, and etiological changes in a target population before and after vaccine intervention. The incidence rate of HFMD decreased from 39.02‰ in 2014 to 11.02‰ in 2021, with a decrease rate of 71.7%, and the decrease was statistically significant (p < 0.001). The number of hospitalized cases decreased by 68.88%, the number of severe cases dropped by 95.60% and the number of deaths dropped to 0. The proportion of cases caused by the EV71 virus in different populations decreased significantly after the intervention, specifically, by 68.41% among individuals 0–4 years of age, by 74.32% among kindergarten children, by 86.07% in severe cases and by 100% with respect to the number of deaths.

Funder

Fujian provincial Medical Innovation Grant

Institute of Medical Biology

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Reference19 articles.

1. Enteroviruses;Muir;Medicine,2014

2. Epidemiological characteristics of school public health emergencies in Fujian Province from 2004 to 2013;Huang;Prev. Med. Forum.,2015

3. National Health and Family Planning Commission of the People’s Republic of China (2008). Notice of the Ministry of Health on Incorporating Hand, Foot and Mouth Disease into the Management of Notifiable Infectious Diseases.

4. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of Hand Foot and Mouth Disease in Fuyang city of China;Zhang;Virol. J.,2010

5. Enterovirus 71 outbreak in the People’s Republic of China in 2008;Yang;J. Clin. Microbiol.,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3